TAK – takeda pharmaceutical company limited american depositary shares (each representing 1/2 of a share of) (US:NASDAQ)

News

????????????:2026???2036?????????? [CNET News]
FDA Grants Priority Review for Takeda (TAK) and Protagonist's Rusfertide in PV Treatment [Yahoo! Finance]
Takeda Pharmaceutical (TAK) was upgraded by Zacks Research from "strong sell" to "hold".
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Takeda plans to lay off 400 employees in US - report [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com